Brazilein inhibits epithelial-mesenchymal transition (EMT) and programmed death ligand 1 (PD-L1) expression in breast cancer cells.

[1]  Lijuan Wang,et al.  IFN-γ induces PD-L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD-L1 in Glioblastoma , 2022, Computational intelligence and neuroscience.

[2]  Chiou-Feng Lin,et al.  Epithelial-to-mesenchymal transition hinders interferon-γ-dependent immunosurveillance in lung cancer cells. , 2022, Cancer letters.

[3]  N. Almansour.  Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence , 2022, Frontiers in Molecular Biosciences.

[4]  T. Gathani,et al.  Understanding breast cancer as a global health concern , 2021, The British journal of radiology.

[5]  P. Kongtawelert,et al.  Atorvastatin Attenuates Programmed Death Ligand-1 (PD-L1) Induction in Human Hepatocellular Carcinoma Cells , 2021, International journal of molecular sciences.

[6]  R. Scolyer,et al.  Programmed death ligand-1 (PD-L1) as a predictive marker for immunotherapy in solid tumours: a guide to immunohistochemistry implementation and interpretation. , 2020, Pathology.

[7]  G. Raghavan,et al.  Color and molecular structure alterations of brazilein extracted from Caesalpinia sappan L. under different pH and heating conditions , 2020, Scientific Reports.

[8]  P. Kongtawelert,et al.  Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin. , 2020, International immunopharmacology.

[9]  Jiayu Zhang,et al.  PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer , 2020, Oncology letters.

[10]  D. Ribatti,et al.  Epithelial-Mesenchymal Transition in Cancer: A Historical Overview , 2020, Translational oncology.

[11]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[12]  Lianhong Li,et al.  PD-1/PD-L1 pathway: current researches in cancer. , 2020, American journal of cancer research.

[13]  P. Kongtawelert,et al.  Inhibitory Effect of Hesperidin on the Expression of Programmed Death Ligand (PD-L1) in Breast Cancer , 2020, Molecules.

[14]  M. Hung,et al.  Mechanisms Controlling PD-L1 Expression in Cancer. , 2019, Molecular cell.

[15]  A. Damjanović,et al.  Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer—How We Can Rise to the Challenge , 2019, Cells.

[16]  Y. Maehara,et al.  IFN-γ Promotes Epithelial-Mesenchymal Transition and the Expression of PD-L1 in Pancreatic Cancer. , 2019, The Journal of surgical research.

[17]  S. M. Toor,et al.  Immune checkpoint inhibitors: recent progress and potential biomarkers , 2018, Experimental & Molecular Medicine.

[18]  K. Mrozik,et al.  N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer , 2018, BMC Cancer.

[19]  V. Mittal.  Epithelial Mesenchymal Transition in Tumor Metastasis. , 2018, Annual review of pathology.

[20]  Shengfeng Qiu,et al.  IFN-γ Induces Gastric Cancer Cell Proliferation and Metastasis Through Upregulation of Integrin β3-Mediated NF-κB Signaling , 2018, Translational oncology.

[21]  Nan Zhang,et al.  PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer , 2017, International Journal of Clinical Oncology.

[22]  F. Azuaje,et al.  CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT , 2017, Oncoimmunology.

[23]  Dianna A. Johnson,et al.  Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma , 2017, BMC Cancer.

[24]  F. Lei,et al.  Brazilein inhibits neuronal inflammation induced by cerebral ischemia and oxygen-glucose deprivation through targeting NOD2 expression. , 2016, Chinese journal of natural medicines.

[25]  Xuetao Cao,et al.  Immunosuppressive cells in tumor immune escape and metastasis , 2016, Journal of Molecular Medicine.

[26]  J. Krstić,et al.  Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF‐7 breast cancer cells via transforming growth factor‐β1 , 2016, IUBMB life.

[27]  Joyce Lee,et al.  PI3K/Akt/mTOR inhibitors in breast cancer , 2015, Cancer biology & medicine.

[28]  S. Hochwald,et al.  The role of FAK in tumor metabolism and therapy. , 2014, Pharmacology & therapeutics.

[29]  R. O'Regan,et al.  The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers , 2014, Therapeutic advances in medical oncology.

[30]  P. Sharma,et al.  PD-L1 Expression in Triple-Negative Breast Cancer , 2014, Cancer Immunology Research.

[31]  B. Demirkan.  The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment , 2013, Journal of clinical medicine.

[32]  B. Zhou,et al.  The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.

[33]  Jian-ye Zhang,et al.  Brazilein, a compound isolated from Caesalpinia sappan Linn., induced growth inhibition in breast cancer cells via involvement of GSK-3β/β-Catenin/cyclin D1 pathway. , 2013, Chemico-biological interactions.

[34]  Y. Wu,et al.  Brazilein suppresses migration and invasion of MDA-MB-231 breast cancer cells. , 2013, Chemico-biological interactions.

[35]  Jin Zeng,et al.  PI3K/Akt to GSK3β/β-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. , 2012, Cellular signalling.

[36]  H. Park,et al.  Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry. , 2012, Breast.

[37]  M. van Engeland,et al.  Characteristics of triple-negative breast cancer , 2010, Journal of Cancer Research and Clinical Oncology.

[38]  Michael K. Wendt,et al.  Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-β signaling and metastasis , 2009, Breast Cancer Research.

[39]  R. Jänicke.  MCF-7 breast carcinoma cells do not express caspase-3 , 2009, Breast Cancer Research and Treatment.

[40]  Jian Wu,et al.  Protosappanin a, an immunosuppressive constituent from a Chinese herb, prolongs graft survival and attenuates acute rejection in rat heart allografts. , 2008, Transplantation proceedings.

[41]  Dongming Xing,et al.  Determination of brazilein in rat plasma after intravenous administration by HPLC. , 2008, Biomedical chromatography : BMC.

[42]  Wei Li,et al.  A new homoisoflavan from Caesalpinia sappan , 2008, Journal of Natural Medicines.

[43]  L. Du,et al.  Study on Cardioactive Effects of Brazilein , 2006, Pharmacology.

[44]  D. Ferrari,et al.  Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. , 2002, Molecular biology of the cell.

[45]  B. Nam-In,et al.  NMR assignment of brazilein , 1997 .

[46]  M. Takeichi.  Cadherins in cancer: implications for invasion and metastasis. , 1993, Current opinion in cell biology.

[47]  Katarzyna A Rejniak,et al.  Circulating Tumor Cells: When a Solid Tumor Meets a Fluid Microenvironment. , 2016, Advances in experimental medicine and biology.

[48]  Q. Wang,et al.  Sonic hedgehog signaling pathway induces cell migration and invasion through focal adhesion kinase/AKT signaling-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9 in liver cancer. , 2013, Carcinogenesis.

[49]  S. Zheng,et al.  Brazilein inhibits survivin protein and mRNA expression and induces apoptosis in hepatocellular carcinoma HepG2 cells. , 2009, Neoplasma.

[50]  D. Peeper,et al.  Metastasis mechanisms. , 2009, Biochimica et biophysica acta.